Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET): One Single Center, Safety and Feasibility Study

NCT04664933 is registered in ClinicalTrials.gov with Hui-Sheng Chen as lead sponsor.

NCT NCT04664933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET): One Single Center, Safety and Feasibility Study
Lead sponsor
Hui-Sheng Chen
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2020
Completion date
May 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intravascular thrombosis, mechanical thrombectomy, stroke, ischemic